Household Healthcare Sector

Viemed Healthcare

Market Cap: US$262.8m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

Healwell AI

Market Cap: CA$358.4m

A healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.

Animalcare Group

Market Cap: UK£193.2m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

AirSculpt Technologies

Market Cap: US$259.2m

Focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.

Mayne Pharma Group

Market Cap: AU$402.2m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Sanara MedTech

Market Cap: US$257.7m

A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.

Neuronetics

Market Cap: US$257.4m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Monte Rosa Therapeutics

Market Cap: US$257.1m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

Inozyme Pharma

Market Cap: US$256.3m

A clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function.

Tonix Pharmaceuticals Holding

Market Cap: US$256.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Allogene Therapeutics

Market Cap: US$255.9m

A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.

Vanda Pharmaceuticals

Market Cap: US$255.8m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

ZimVie

Market Cap: US$255.2m

Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.

Atea Pharmaceuticals

Market Cap: US$254.2m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Alpha Tau Medical

Market Cap: US$252.8m

A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

Gossamer Bio

Market Cap: US$252.3m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

Lifecore Biomedical

Market Cap: US$250.7m

Operates as an integrated contract development and manufacturing organization in the United States.

Rezolute

Market Cap: US$249.4m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Solid Biosciences

Market Cap: US$248.8m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Cartesian Therapeutics

Market Cap: US$248.1m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Prothena

Market Cap: US$247.1m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Ocugen

Market Cap: US$244.2m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

Canopy Growth

Market Cap: CA$333.3m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Cerus

Market Cap: US$242.8m

Operates as a biomedical products company.

Neurogene

Market Cap: US$242.6m

A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.

MaxCyte

Market Cap: UK£178.6m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Tango Therapeutics

Market Cap: US$240.6m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Performant Healthcare

Market Cap: US$240.4m

Provides audit, recovery, and analytics services in the United States.

Tenax Therapeutics

Market Cap: US$240.1m

A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

Amarin

Market Cap: US$240.0m

A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.

Tristel

Market Cap: UK£176.5m

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

MediWound

Market Cap: US$237.3m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

Tevogen Bio Holdings

Market Cap: US$237.2m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Third Harmonic Bio

Market Cap: US$235.1m

A biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases.

Jade Biosciences

Market Cap: US$233.7m

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

Actuate Therapeutics

Market Cap: US$233.5m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.